Breaking News Instant updates and real-time market news.

PM

Philip Morris

$83.08

1.26 (1.54%)

12:45
10/02/18
10/02
12:45
10/02/18
12:45

Philip Morris call volume above normal and directionally bullish

Bullish option flow detected in Philip Morris with 5,997 calls trading, 1.2x expected, and implied vol increasing over 1 point to 22.78%. Jan-19 92.5 calls and 10/5 weekly 83.5 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.46. Earnings are expected on October 18th.

PM Philip Morris
$83.08

1.26 (1.54%)

08/24/18
JEFF
08/24/18
DOWNGRADE
JEFF
Hold
Jefferies downgrades Philip Morris, Altria Group to Hold from Buy
Jefferies analyst Owen Bennett downgraded both Philip Morris (PM) and Altria Group (MO) to Hold from Buy. The analyst lowered his lowered his price target on the former to $80 from $93 and on the latter to $61 from $70. For Philip Morris, the analyst sees significant share loss in Japan heated in the second half of 2018 and believes its longer-term total tobacco volumes will pressured due to greater skew to vapor. For Altria Group, Bennett believes market share pressures should pick up again the second half of 2018. Further, he sees the company at a disadvantage in vapor due to available formats and believes concerns around the delay of an IQOS approval will likely weigh on the shares. The analyst reiterates a Buy rating on shares of British American Tobacco (BTI).
08/24/18
08/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. L Brands (LB) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Kimberly Greenberger saying the Victoria's Secret turnaround is taking longer than anticipated and she now sees greater risk to 2019 estimates. 2. Hormel Foods (HRL) downgraded to Equal Weight from Overweight at Barclays with analyst Benjamin Theurer saying he is taking a more neutral view on the shares citing the supply/demand imbalance in the pork business, uncertainty in the international segment from trade tariffs, and the "sluggish performance" of its other businesses. 3. Cummins (CMI) downgraded to Underweight from Neutral at JPMorgan with analyst Ann Duignan saying with demand for trucks in China slowing, and lingering investor concerns over a peaking truck cycle in North America, she sees downside risks for the shares. 4. Secureworks (SCWX) downgraded to Sell from Neutral at UBS WITH analyst Fatima Boolani citing valuation. 5. Altria Group (MO) and Philip Morris (PM) were downgraded to Hold from Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/18
WELS
09/20/18
NO CHANGE
WELS
Outperform
Tobacco stocks to rally on PM USA price increase, says Wells Fargo
Wells Fargo analyst Bonnie Herzog says Altria Group (MO) and Philip Morris (PM) just announced a "healthy and slightly higher than expected" wholesale list price increase on all of its cigarette brands, including Marlboro The analyst learned from industry contacts that PM USA took a cigarette list price increase of 10c per pack or $1.00 per carton on Marlboro, L&M, and B&H Menthol, 15c per pack on Parliament and Virginia Slims, and 50c per pack on everything else. The 10c per pack increase on Marlboro is slightly higher than the 9c per pack increase Altria took on Marlboro in March 2018, reflecting the company's "significant pricing power," Herzog tells investors in a research note. The analyst expects British American Tobacco (BTI), Reynolds and ITG Brands will follow Altria's lead and increase prices in the next few days, but possibly not as robust of an increase. She expects Tobacco stocks will react favorably to this list price increase and reiterates an Overweight rating on the sector and Outperform rating on Altria Group.Fargo
09/27/18
PIPR
09/27/18
NO CHANGE
Target $99
PIPR
Overweight
Philip Morris medium-term targets likely beatable, says Piper Jaffray
Piper Jaffray analyst Michael Lavery says Philip Morris updated its 2018 guidance for currency and gave medium-term guidance, with a medium-term objective of 5% or better organic sales growth and 8% or better earnings growth. The analyst considers these targets "to be realistic and achievable, and likely even beatable." The company also announced implementation of zero-based budgeting, which is expected to drive $1B of annualized cost savings by 2021, Lavery tells investors in a research note. Further, Philip Morris revised guidance for currency to reflect a 12c hit and now expects earnings per share in a range of $4.97-$5.02, down from $5.02-$5.12, the analyst points out. Lavery keeps an Overweight rating on the shares with a $99 price target.

TODAY'S FREE FLY STORIES

GPI

Group 1 Automotive

$63.62

2.05 (3.33%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Hot Stocks
Group 1 Automotive raises share repurchase authorization to $75M »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 06

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Earnings
Breaking Earnings news story on OGE Energy »

OGE Energy sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AERI

Aerie Pharmaceuticals

$39.56

-1.25 (-3.06%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
OGE Energy reports Q4 EPS 27c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
Brady raises FY19 EPS view to $2.25-$2.35 from $2.20-$2.30, consensus $2.28 »

Backs FY19 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

VRCA

Verrica Pharmaceuticals

$10.99

-0.12 (-1.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Initiation
Verrica Pharmaceuticals initiated  »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ARRS

Arris

$31.65

0.025 (0.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Earnings
Arris reports preliminary Q4 adjusted EPS 76c, consensus 75c »

Reports Q4 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Hot Stocks
Wendy's approves new $225M share repurchase program »

At the end of 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

QEP

QEP Resources

$8.19

-0.08 (-0.97%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Recommendations
QEP Resources analyst commentary  »

Elliott may push for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Earnings
Brady reports Q2 EPS 55c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

AVB

AvalonBay

$194.14

-2.37 (-1.21%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Downgrade
AvalonBay rating change  »

Citi downgrades AvalonBay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Hot Stocks
Breaking Hot Stocks news story on Ardagh Group »

Ardagh Group sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Ardagh Group sees FY19 adjusted EPS $1.60-$1.75, consensus $1.76 »

2019 outlook: Full year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Independence Realty sees FY19 EPS 76c-80c, may not compare to consensus 24c 

Sees FY19 CFFO 74c-78c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Wendy's sees FY20 global systemwide sales of approximately $11.5B »

Sees FY20 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

ALB

Albemarle

$82.82

-0.305 (-0.37%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Albemarle analyst commentary  »

Oppenheimer says remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$63.83

7.19 (12.69%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Belden analyst commentary  »

Belden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

  • 14

    May

  • 15

    May

MCRN

Milacron

$14.78

0.13 (0.89%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Milacron sees FY19 pro forma sales growth 0%-1%, consensus $1.28B »

In line with current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Ardagh Group reports Q4 adjusted EPS 33c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Independence Realty Trust reports Q4 EPS 16c, consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Wendy's sees FY19 adjusted EPS growth of 3.5%-7%, consensus 66c »

Sees FY19 global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

BTX

BioTime

$1.16

-0.11 (-8.66%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Initiation
BioTime initiated  »

BioTime initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FARO

Faro Technologies

$43.78

-4.16 (-8.68%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Downgrade
Faro Technologies rating change  »

Faro Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.